Abstract. The aim of the present study was to assess the curative effect of combined phacoemulsification, 23-gauge pars plana vitrectomy with Brilliant blue G-assisted limiting membrane peeling and gas tamponade in patients with coexisting idiopathic macular hole (IMH) and age-associated cataract. A total of 21 consecutive patients (21 eyes) with coexisting IMH and age-associated cataract were enrolled in the study. All patients were treated by 23-gauge microincision vitrectomy with internal limiting membrane peeling, gas tamponade and combined phacoemulsification. The pre-operative MH diameter, MH index and best-corrected visual acuity (BCVA), as well as events of post-operative MH closure and complications were recorded and analyzed. Anatomic closure of the MH was achieved in 19 eyes (90.4%) with a single surgery. The LogMAR BCVA value at 1 month after surgery and the final follow-up visit was significantly lower than the baseline value (P= 0.0036 and P= 0.0015, respectively). A significant correlation was identified between the MH index and the post-operative LogMAR BCVA (r= 0.869; P<0.001). The combined technique applied in the present study produced favorable anatomic and functional results for patients with coexisting IMH and age-associated cataracts. The pre-operative MH size measured by optical coherence tomography may serve as a predictive factor for the LogMAR BCVA value following MH surgery.
Introduction
Idiopathic macular holes (IMH) are a major vitreoretinal pathology that may cause metamorphopsia and poor central vision (1, 2) . IMH mainly occurs in individuals aged 60-70 years, with ~66.7% of those affected being female (3) (4) (5) (6) .
In the past, MHs were considered to be incurable. Vitrectomy in combination with intraocular gas tamponade was the first remedy for MHs with a prominent success rate (7, 8) . Various adjunctive therapeutic strategies have also been introduced for MH treatment. Internal limiting membrane (ILM) peeling, an alternative treatment method, may increase the probability of primary anatomical closure of MHs (9) (10) (11) . Previous studies have confirmed the safety and reliability of the 25-gauge vitrectomy system with sutureless self-sealing sclerotomies in the treatment of various vitreoretinal diseases (12, 13) . The 23-gauge transconjunctival system was then proposed, which combined the merits of 25-and 20-gauge instrumentation (14) . In general, small-gauge transconjunctival vitrectomy has gained wide recognition due to its intra-and post-operative superiority, as it involves less pain, a shorter surgical time and a lower rate of post-operative inflammation (13) .
Closed pars plana vitrectomy remains the primary treatment option for a large number of patients with IMH (15) . Despite the great progress made in transconjunctival vitrectomy and the high post-operative anatomic success (7, (16) (17) (18) , visual recovery is far from satisfactory among patients with MHs (19, 20) . Cataract progression is the most common complication following MH surgery, often deeming a second surgery necessary within 2 years. As elderly patients commonly present with MHs, numerous eyes affected may have concomitant IMH and cataracts. ILM peeling may be a beneficial adjunctive procedure for MH surgery and has been reported to increase MH closure rates (15) . However, it is a complex procedure due to the lens opacity of the eyes of patients with IMH accompanied by cataracts (21) .
The aim of the present study was to assess the curative effect of combined phacoemulsification, 23-gauge pars plana vitrectomy with Brilliant blue G (BBG)-assisted ILM peeling and gas tamponade in patients with IMH and age-associated cataracts.
the Department of Ophthalmology, Hebei General Hospital (Shijiazhuang, China) from January to November 2016 were enrolled in the present study. All patients were subjected to 23-gauge microincision vitrectomy, air tamponade and phacoemulsification. The study was approved by the institutional review board of Hebei General Hospital (Shijiazhuang, China). Written informed consent was obtained from each patient prior to surgery and each patient consented for their information to be used for the purpose of research.
Prior to the surgery, all patients received ophthalmic examinations, which included best-corrected visual acuity (BCVA) assessment, slit-lamp biomicroscopic examination, intraocular pressure measurement and indirect ophthalmoscopic examinations. The diagnosis of IMH was made based on fundus examination and optical coherence tomography (OCT). The IMH grading system used was the Gass classification (22) .
The inclusion criteria included stage 2-4 IMH accompanied by age-associated cataracts. The exclusion criteria were high myopia (>8D), history of retinal diseases, diabetes and traumatic MH, history of vitreoretinal surgery, MH stage 1, macular cysts or secondary MHs.
Surgical technique. All surgeries were performed by a single experienced vitreoretinal surgeon using a Stellaris PC system (Bausch & Lomb Inc., Bridgewater, NJ, USA). Following superficial anesthesia with 3 ml proxymetacaine (Alcon, Fort Worth, TX, USA) and retrobulbar anesthesia with a (1:1) mixture of 2% lidocaine and 0.75% bupivacaine (3 ml), phacoemulsification surgery was performed via a 3.2-mm sclera tunnel incision. An ophthalmic viscosurgical device was used to expand and stabilize the capsular bag, in order to facilitate the implantation of a foldable water-based acrylic intraocular lens into the capsular bag. A three-port 23-gauge vitrectomy was then performed. During the vitrectomy, a posterior vitreous detachment was performed and the remnant posterior vitreous cortex was removed. Peripheral vitreous detachment was then performed. Following visualization using BBG dye [ILM Blue ® ; Dutch Ophthalmic Research Center (International) B.V., Zuidland, the Netherlands], the ILM was peeled off around the MH using a pair of ILM forceps. Fluid-air exchange and intraocular tamponade with sterilized air was applied at the end of the procedure. Following surgery, all patients were instructed to maintain a face-down position for 2-3 days at the hospital.
Post-operative treatment consisted of Tobramycin Dexamethasone eye drops (Alcon), Pranoprofen eye drops (SENJU Pharmaceutical Co., Ltd., Osaka, Japan) for anti-inflammatory therapy and Tropicamide eye drops (Shenyang Xingqi Pharmaceutical Co., Ltd., Shengyang, China) for mydriasis treatment.
Clinical evaluation. The recorded data included the pre-operative MH diameter, the MH index (MHI), the LogMAR BCVA, as well as events of post-operative MH closure and any potential intra-and post-operative complications. The MH diameter, MHI and BCVA were measured at 1 month post-surgery and at the last follow-up. MH closure was considered an anatomical success when no neurosensory defects were observed in the fovea on ophthalmoscopy with confirmation by OCT (23) . Post-operative complications were observed by slit-lamp biomicroscopy, indirect funduscopy and intraocular pressure assessment.
Statistical analysis. Quantitative data are expressed as the mean ± standard deviation and analyzed using repeated-measures analysis of variance followed by the Bonferroni test. Qualitative data are presented as numbers and/or percentages and were analyzed using the χ 2 or Fisher's exact test, as appropriate. Correlation between the pre-operative MH diameter and the post-operative LogMAR BCVA was analyzed using a Spearman rank correlation analysis. Statistical analysis was performed using SPSS 19.0 software (IBM Corp., Armonk, NY, USA). P<0.05 was considered to indicate a statistically significant difference. (Fig. 1) , while 2 eyes did not achieve MH closure following initial surgery. These latter 2 patients were asked to maintain a face-down position for 2 weeks after the MHs were sealed using autologous serum and silicone oil tamponades. Anatomical closure of the MHs and improvement in VA was observed in these 2 cases at 1 month after surgery. A higher MH closure rate was observed in patients with an MH diameter of ≤600 µm, as compared with that in patients with an MH diameter of >600 µm; however, the difference was not significant (P= 0.13). No significant association was observed between MH index and closure rate (P=0.48; Table II) .
BCVA. The mean pre-operative LogMAR BCVA was 1.22±0.42. Following combined surgery, the mean LogMAR BCVA decreased to 0.82±0.43 and 0.75±0.47, at 1 month post-surgery and the last follow-up, respectively. A significant decrease in the LogMAR BCVA was observed at 1 month post-surgery (P=0.0036) and at the last follow-up (P=0.0015), as compared with the baseline levels ( Fig. 2A) . Spearman rank correlation analysis revealed a positive correlation between the pre-operative MH diameter and the post-operative LogMAR BCVA (r=0.869, P<0.001; Fig. 2B ).
Intraocular pressure. The intraocular pressure prior to surgery, at post-operative month 1 and the last follow-up was 12.3±2.2, 14.8±3.7 and 11.4±2.8 mmHg, respectively. No statistically significant difference in intraocular pressure from baseline was observed at 1 month post-surgery and at the final follow-up (all P>0.05; Fig. 2C ).
Complications. Post-operative vitreous hemorrhage was observed in 2 eyes and they were successfully treated by vitreous lavage. No choroidal detachment or endophthalmitis was recorded.
Discussion
IMHs are full-thickness defects of the retinal tissue involving the anatomic fovea. They may affect central visual acuity and even cause metamorphopsia. As MH commonly occurs in aged patients, numerous eyes affected may have concomitant MH and cataract. Despite the great progress in transconjunctival vitrectomy and high anatomic success after surgery, visual recovery in MH patients is far from satisfactory. Therefore, a more efficient surgical method is necessary. The success rate of MH surgery has been increased to 90% since MH repair was first described (24) . However, few studies have assessed combined phacoemulsifcation with 23-gauge pars plana vitrectomy with BBG-assisted ILM peeling and gas tamponade (13, 25, 26) . The present study combined cataract and MH surgery, including phacoemulsifcation, 23-gauge pars plana vitrectomy, BBG-assisted ILM peeling and gas tamponade. All patients received phacoemulsification, pars plana vitrectomy, ILM peeling and fluid-gas exchange, and a face-down position was adopted for several days after the surgery. The MH closure rate of 90.4% determined in the present study was consistent with the success rates reported in previous studies (27) (28) (29) . Rizzo et al (27) revealed that MH closure rate was 93% following the use of a sutureless 25-gauge vitrectomy (27) . Furthermore, the macular hole closure rate was ~90% with sulfur hexafluoride gas or perfluoropropane gas (28) . A comparatively higher MH closure rate was observed in patients with a hole diameter of ≤600 µm, but no significant difference was observed. These results were inconsistent with those of previous studies reporting that a smaller MH is associated with a better prognosis regarding post-operative anatomical closure (30) (31) (32) . This contradiction may be due to the fact that the sample size of the present study was too small to reach statistical significance. Therefore, further studies with a larger sample size are required to clarify this. The effect of the pre-operative MHI on post-operative anatomical closure was also determined. The present data indicated that the MHI had no significant predictive value. By contrast, Kusuhara et al (33) reported that an MHI of ≥0.5 is a positive predictive factor for a favorable surgical outcome. This contradiction may be due to the fact that the present study included a small number of cases and that large inter-individual differences were present. Furthermore, the results indicated a positive correlation between the pre-operative MH diameter and the post-operative LogMAR BCVA. This suggests that the pre-operative MH size measured by OCT may provide a predictive factor for the LogMAR BCVA after MH surgery. Therefore, apart from proposing another effective combined surgical method, the present study may also provide a potential predictor for the treatment outcome of MH. The 23-gauge vitrectomy system allows for a small incision, self-sealing and sutureless transconjunctival pars plana sclerotomies, which renders it superior to the traditional 20-gauge vitrectomy system (34) . In the present study, 2 eyes presented with post-operative vitreous hemorrhage, which was thought to be associated with sutureless transconjunctival pars plana sclerotomies and low intraocular pressure in the affected patients at the end of the air tamponade.
MHs often occur in aged/elderly individuals, and thus, certain patients may present with co-existing MH and cataract. Due to blurred media, vitrectomy surgery becomes more difficult. Combined cataract extraction and vitrectomy has been regarded as an effective method for the treatment of various vitreoretinal diseases (21,25,26,35-37 ).
Muselier et al (21) reported that combined and consecutive surgeries produced equivalent functional and anatomical results. Combined cataract and MH surgery has been reported to be more advantageous than consecutive surgeries, as it avoids a second surgical procedure and is more convenient for the vitreoretinal surgeon (38) . In addition, in this study, a faster visual recovery was observed following the combined surgery; thus, a second surgery was avoided and the overall surgical cost was reduced. A previous study by Hikichi et al (13) has confirmed the effectiveness of 23-gauge vitrectomy with air tamponade and combined phacoemulsification, but without the BBG-assisted ILM peeling, for IMH. However, the cases included were of IMH with no cataracts. The present study assessed the combined surgery in patients with coexisting IMH and age-associated cataracts. Demetriades et al (26) have reported that combined phacoemulsification, intraocular lens implantation and vitrectomy is a reasonable alternative in patients with coexisting cataract and vitreoretinal pathology. However, the combined surgery was not applied for the treatment of MH. Thus, the present study provided a novel effective combined surgery for the treatment of patients with coexisting MHs and cataracts.
Combining surgeries has numerous advantages (21, (38) (39) (40) (41) . First, patients do not require a second surgical procedure. Furthermore, it is beneficial for extending vitrectomy, which contributes to the removal of the anterior vitreous. Increasing the gas volume may provide a longer tamponade, which may prove beneficial for the closure of the MH. Nuclear sclerotic cataract progression has been associated with the use of vitrectomy for the treatment of MHs (42) . Therefore, combined cataract extraction and vitrectomy may help avoid the adverse effects of cataract progression despite improvement in visual acuity. Muselier et al (21) reported a marked difference in visual acuity improvement at 0.5 years after surgery between patients who underwent vitrectomy alone and those who underwent vitrectomy combined with cataract extraction for the treatment of MHs. The study concluded that cataract progression following vitreous surgery may have been due to the slower recovery of patients who received a separate vitrectomy (21) .
The present study had certain limitations. First, it lacks a concurrent control group. Furthermore, all procedures were performed by a single surgeon, thereby failing to compare the differences in clinical outcomes between different surgical procedures or surgeons. Finally, the size of the study population was small due to the strict inclusion and exclusion criteria. However, the present results may be representative for a patient population similar to that of the present study, namely those with coexisting IMH and age-associated cataract.
In conclusion, combined phacoemulsification with 23-gauge pars plana vitrectomy with BBG-assisted ILM peeling and gas tamponade yielded satisfactory anatomic and functional results for patients with IMH and age-associated cataracts. The pre-operative MH size measured by OCT may be a predictive factor for the LogMAR BCVA after MH surgery.
